Cargando…
Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516577/ https://www.ncbi.nlm.nih.gov/pubmed/32980540 http://dx.doi.org/10.1016/j.tmaid.2020.101886 |
| _version_ | 1783587033729466368 |
|---|---|
| author | Bigna, Jean Joel Kamtchum-Tatuene, Joseph Noubiap, Jean Jacques |
| author_facet | Bigna, Jean Joel Kamtchum-Tatuene, Joseph Noubiap, Jean Jacques |
| author_sort | Bigna, Jean Joel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7516577 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75165772020-09-25 Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence Bigna, Jean Joel Kamtchum-Tatuene, Joseph Noubiap, Jean Jacques Travel Med Infect Dis Correspondence Elsevier Ltd. 2020 2020-09-25 /pmc/articles/PMC7516577/ /pubmed/32980540 http://dx.doi.org/10.1016/j.tmaid.2020.101886 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Bigna, Jean Joel Kamtchum-Tatuene, Joseph Noubiap, Jean Jacques Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence |
| title | Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence |
| title_full | Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence |
| title_fullStr | Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence |
| title_full_unstemmed | Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence |
| title_short | Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence |
| title_sort | claims about the safety and efficacy of early treatment of covid-19 with hydroxychloroquine and azithromycin must be supported by real evidence |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516577/ https://www.ncbi.nlm.nih.gov/pubmed/32980540 http://dx.doi.org/10.1016/j.tmaid.2020.101886 |
| work_keys_str_mv | AT bignajeanjoel claimsaboutthesafetyandefficacyofearlytreatmentofcovid19withhydroxychloroquineandazithromycinmustbesupportedbyrealevidence AT kamtchumtatuenejoseph claimsaboutthesafetyandefficacyofearlytreatmentofcovid19withhydroxychloroquineandazithromycinmustbesupportedbyrealevidence AT noubiapjeanjacques claimsaboutthesafetyandefficacyofearlytreatmentofcovid19withhydroxychloroquineandazithromycinmustbesupportedbyrealevidence |